173 related articles for article (PubMed ID: 3259672)
41. The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.
Wehler C; Andrews JM; Bing DH
Mol Immunol; 1981 Mar; 18(3):157-62. PubMed ID: 6973690
[No Abstract] [Full Text] [Related]
42. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
[TBL] [Abstract][Full Text] [Related]
43. An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q binding.
Spaeth PJ; Corvetta A; Nydegger UE; Montroni M; Buetler R
Scand J Immunol; 1983 Oct; 18(4):319-28. PubMed ID: 6606219
[TBL] [Abstract][Full Text] [Related]
44. The effects of cleavage of the inter-chain disulphide bonds of rabbit IgG on its ability to bind C1q.
Sutton J; Alden JR; Easterbrook-Smith SB
Biochim Biophys Acta; 1984 May; 787(1):39-44. PubMed ID: 6609719
[TBL] [Abstract][Full Text] [Related]
45. C1q binding by a high affinity anti-fluorescein murine monoclonal IgM antibody and monomeric subunits.
Swanson SM; Dombrink-Kurtzman MA; Voss EW
Mol Immunol; 1988 Jun; 25(6):545-54. PubMed ID: 2459610
[TBL] [Abstract][Full Text] [Related]
46. C1q binding to antibody-coated cells: predictions from a simple multivalent binding model.
Dower SK; Segal DM
Mol Immunol; 1981 Sep; 18(9):823-9. PubMed ID: 6978459
[No Abstract] [Full Text] [Related]
47. The role of Fc:Fc interactions in insoluble immune complex formation and complement activation.
Easterbrook-Smith SB; Vandenberg RJ; Alden JR
Mol Immunol; 1988 Dec; 25(12):1331-7. PubMed ID: 3237216
[TBL] [Abstract][Full Text] [Related]
48. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
Fiocco GP; Davis JS; Burge JJ
Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
[No Abstract] [Full Text] [Related]
49. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
50. An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.
Samuel DJ; Amlot PL; Shepherd P; Lachmann PJ
Clin Exp Immunol; 1986 Aug; 65(2):458-64. PubMed ID: 3491710
[TBL] [Abstract][Full Text] [Related]
51. Rat polymeric IgA binds C1q, but does not activate C1.
Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
[TBL] [Abstract][Full Text] [Related]
52. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
53. A reinterpretation of the evidence for an interaction between Clq and pairs of immunoglobulin molecules in an immune lattice.
Spouge JL; Easterbrook-Smith SB
Mol Immunol; 1982 Feb; 19(2):253-6. PubMed ID: 6980369
[TBL] [Abstract][Full Text] [Related]
54. Complement C1q binding affects spin-labeled heterosaccharides of rabbit antibodies in immune but not artificial immunoglobulin G aggregates.
Winkelhake JL; Kusumi A; McKean L; Mandy WJ
J Biol Chem; 1984 Feb; 259(4):2171-8. PubMed ID: 6199346
[TBL] [Abstract][Full Text] [Related]
55. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
56. Failure of oligosaccharide MOPC-104E IgM complexes to bind C1q and to activate C1.
Weiner EM
Biochem Int; 1987 Jul; 15(1):163-8. PubMed ID: 3502595
[TBL] [Abstract][Full Text] [Related]
57. Immune complexes and complement components in Bell's palsy.
Jonsson L; Larsson A; Thomander L
ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
[TBL] [Abstract][Full Text] [Related]
58. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
Hsiung L; Dodds AW; Mason DW; Reid KB
FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
Levinson SS; Goldman JO
J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
[TBL] [Abstract][Full Text] [Related]
60. The modulation of immune complex aggregation by classical pathway-mediated reactions.
Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
